Services on Demand
Journal
Article
Indicators
Cited by SciELO
Related links
Similars in
SciELO
Share
Medicina clínica y social
On-line version ISSN 2521-2281
Abstract
ROLON, Ángel et al. Traditional and Infusion-Based Yerba Mate Consumption and Lipid Profile in Adults: A Systematic Review and Meta-analysis. Med. clín. soc. [online]. 2026, vol.10, n.1, e732. Epub Sep 21, 2026. ISSN 2521-2281. https://doi.org/10.52379/mcs.v10.732.
Introduction:
Yerba mate (Ilex paraguariensis), widely consumed in South America, contains polyphenols, methylxanthines and saponins that may influence cardiometabolic pathways. Evidence on its effects on lipid profile remains heterogeneous, especially between traditional infusion-based consumption and extracts or low-dose preparations.
Objective:
To synthesize the evidence on traditional or infusion-based yerba mate consumption and lipid profile in adults.
Methodology:
Systematic review and meta-analysis across PubMed/MEDLINE, Scopus, Web of Science, BVS/LILACS and Cochrane CENTRAL, covering human studies in adults on yerba mate exposure and lipid-profile outcomes. Random-effects meta-analyses used mean differences in mg/dL, in a primary controlled analysis against control or active comparators and a secondary pre-post analysis of within-group changes.
Results:
Of 173 records, nine studies were included and seven contributed to at least one meta-analysis. In the primary controlled meta-analysis, yerba mate was not associated with significant changes in total cholesterol (MD 0.49 mg/dL; 95% CI -7.00 to 7.98), LDL-C (MD 0.74; 95% CI -6.10 to 7.58), HDL-C (MD -0.00; 95% CI -1.83 to 1.82) or triglycerides (MD 1.77; 95% CI -2.86 to 6.40). Pre-post analyses showed within-group reductions in total cholesterol (-11.02 mg/dL), LDL-C (-10.90) and triglycerides (-6.18), with a small decrease in HDL-C (-1.26).
Conclusion:
Controlled evidence did not confirm significant lipid changes attributable to yerba mate. Pre-post analyses suggested a within-group lipid-lowering signal, particularly for total cholesterol and LDL-C, but causal interpretation remains limited by study design, comparator heterogeneity and risk of bias. Better powered randomized trials using standardized traditional preparations are needed.
Keywords : Yerba mate; Cholesterol; Cholesterol, LDL; Cholesterol, HDL; Triglycerides; Lipids; Systematic review; Meta-analysis.











